Nephrology Doctors in Jonesboro, AR Accepting Medicare

5 Nephrology doctors found. Showing 1 - 5

Gerren Hobby, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4802 E Johnson Ave, Jonesboro, AR 72401 Phone: 870-936-8000    Fax: 870-934-3640

Clinton Brough Edwards, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 300 Carson St, Jonesboro, AR 72401 Phone: 870-932-1198    Fax: 970-910-7709

Dr. Michael G Mackey, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4802 E Johnson Ave, Jonesboro, AR 72401 Phone: 870-936-8000    Fax: 870-934-3640

Adam Woodruff, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4802 E. Johnson Ave, Jonesboro, AR 72401 Phone: 870-936-8210    Fax: 870-934-3640

James Maxwell, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 300 Carson St, Jonesboro, AR 72401 Phone: 870-932-1198

News Archive

ARIAD's ponatinib initial Phase 1 study data on acute myeloid leukemia to be presented at ASCO 2011

ARIAD Pharmaceuticals, Inc. today announced initial clinical findings on ponatinib in patients with advanced acute myeloid leukemia (AML).

FDA panel to review Cameron Health S-ICD System PMA application

Cameron Health, Inc. announced today that the U.S. Food and Drug Administration Circulatory System Devices Panel will review the Premarket Approval (PMA) application of the S-ICD System on April 26, 2012.

Researchers use DNA to drive the assembly of 3D gold structures

DNA is the blueprint of all life, giving instruction and function to organisms ranging from simple one-celled bacteria to complex human beings.

Canadian researchers launch world's first viral therapy clinical trial to attack and kill cancer cells

Canadian researchers have launched the world's first clinical trial of a novel investigational therapy that uses a combination of two viruses to attack and kill cancer cells, and stimulate an anti-cancer immune response. Previous research by this team and others worldwide suggests that this approach could be very powerful, and could have fewer side effects than conventional chemotherapy and radiation, although it will take years to rigorously test through this trial and others.

Read more Medical News

› Verified 6 days ago